Diffuse Large B-cell Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-17Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating rituximab with combination chemotherapy in diffuse large B-cell non-Hodgkin's lymphoma has completed enrollment and…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating Y-90 ibritumomab tiuxetan with rituximab for relapsed or refractory diffuse large B-cell non-Hodgkin's lym…
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial update evaluating a combination of chemotherapy and Rituximab for diffuse large B-cell non-Hodgkin lymphoma.